DRTS logo

Alpha Tau Medical Ltd. (DRTS)

Profile

Full Name

Alpha Tau Medical Ltd.

Ticker

NASDAQ: DRTS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

March 8, 2021

Indexes

Not included

Website

https://www.alphatau.com

Employees

125

Key Details

Price

$4.93(-2.38%)

Market Cap

$420.35M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.45(-8.02% YoY)

PE Ratio

-

Next earnings date

Mar 12, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.93
    DRTS price is $4.93

    30-Day Relative Volume

    1.24
    DRTS 30-day relative volume is 1.24

    Price Performance

    Price 1-Day Change

    -2.38%
    DRTS price is down -2.38% today

    Price YTD Change

    +59.03%
    DRTS price is up +59.03% since January 1st

    Price 1-Year Change

    +60.59%
    DRTS price is up +60.59% year-on-year

    Price 3-Year Change

    +52.16%
    DRTS price is up +52.16% over the past 3 years

    Price Range

    Price All-Time High

    $20.65
    DRTS price is currently -76.13% below its historical high of $20.65

    Price 3-Year Low

    $1.75
    DRTS price is currently +181.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $420.35M
    DRTS market cap is $420.35 million

    Market Cap 3-Year Change

    +87.99%
    DRTS market cap is up +87.99% over the past 3 years

    Market Cap All-Time High

    $1.02B
    DRTS market cap is currently -58.70% below its historical high of $1.02 billion

    Market Cap Sector Percentile

    59.24%
    DRTS market cap is higher than 59.24% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +21.63%
    DRTS shares outstanding is up +21.63% year-on-year

    Shares Outstanding 3-Year Change

    +23.55%
    DRTS shares outstanding is up +23.55% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.54
    DRTS beta is 0.54

    200-day SMA

    $3.30
    DRTS price is currently +49.19% above its 200-day simple moving average

    50-day SMA

    $4.01
    DRTS price is currently +22.98% above its 50-day simple moving average

    14-Day RSI

    69.97
    DRTS 14-day relative strength index is 69.97

    Volume

    1.24
    DRTS 30-day relative volume is 1.24

    ATR

    $0.34
    DRTS average true range is $0.34

    10-day Historical Volatility

    114.24%
    DRTS 10-day historical volatility is 114.24%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    DRTS annual revenue is $0.00

    Revenue Analysts Estimate

    -
    DRTS annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    DRTS annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.27%
    DRTS annual revenue is higher than 28.27% of companies in Healthcare sector

    EPS

    EPS

    -$0.45
    DRTS annual earnings per share is -$0.45

    EPS Analysts Estimate

    -$0.51
    DRTS annual earnings per share is currently +11.48% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -8.02%
    DRTS annual earnings per share is down -8.02% year-on-year

    EPS Sector Percentile

    69.08%
    DRTS annual earnings per share is higher than 69.08% of companies in Healthcare sector

    Profit

    Gross Profit

    -$1.10M
    DRTS annual gross profit is -$1.10 million

    Gross Margin

    -
    DRTS annual gross profit margin value is unknown

    Operating Profit

    -$36.04M
    DRTS annual operating income is -$36.04 million

    Operating Margin

    -
    DRTS annual operating profit margin value is unknown

    Net Income

    -$31.75M
    DRTS annual net profit is -$31.75 million

    Net Margin

    -
    DRTS annual net profit margin value is unknown

    Expenses

    Total Expenses

    $36.04M
    DRTS annual total expenses is $36.04 million

    Operating Expenses

    $36.04M
    DRTS annual total operating expenses is $36.04 million

    Cost Of Goods Sold

    $1.10M
    DRTS annual cost of goods sold is $1.10 million

    Selling, General & Administrative Expenses

    $9.02M
    DRTS annual SG&A is $9.02 million

    Depreciation & Amortization

    $1.10M
    DRTS annual D&A is $1.10 million

    Interest Expense

    $0.00
    DRTS annual interest expense is $0.00

    Income Tax

    $6000.00
    DRTS annual income tax is $6000.00

    EBIT & EBITDA

    EBIT

    -$31.44M
    DRTS annual earnings before interest & taxes is -$31.44 million

    EBITDA

    -$30.34M
    DRTS annual EBITDA is -$30.34 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $86.20M
    DRTS annual total assets is $86.20 million

    Non Current Assets

    $21.98M
    DRTS annual long term assets is $21.98 million

    Current Assets

    $64.23M
    DRTS annual total current assets is $64.23 million

    Cash and Cash Equivalents

    $13.72M
    DRTS annual cash & cash equivalents is $13.72 million

    Accounts Receivable

    -
    DRTS annual accounts receivable value is unknown

    Inventory

    $0.00
    DRTS annual inventory is $0.00

    Liabilities

    Total Liabilities

    $23.54M
    DRTS annual total liabilities is $23.54 million

    Long Term Liabilities

    $14.86M
    DRTS annual total long term liabilities is $14.86 million

    Current Liabilities

    $8.68M
    DRTS annual current liabilities is $8.68 million

    Accounts Payable

    $3.53M
    DRTS annual accounts payable is $3.53 million

    Debt

    Total Debt

    $12.54M
    DRTS annual total debt is $12.54 million

    Total Debt 1-Year Change

    -5.57%
    DRTS annual total debt is down -5.57% year-on-year

    Long Term Debt

    $11.53M
    DRTS annual long term debt is $11.53 million

    Short Term Debt

    $1.01M
    DRTS annual short term debt is $1.01 million

    Equity & Capital

    Shareholders Equity

    $62.67M
    DRTS annual stockholders equity is $62.67 million

    Book Value

    $62.67M
    DRTS annual book value is $62.67 million

    Retained Earnings

    -$147.51M
    DRTS annual retained earnings is -$147.51 million

    Working Capital

    $55.55M
    DRTS annual working capital is $55.55 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$19.78M
    DRTS annual cash from operations is -$19.78 million

    Cash From Operations 1-Year Change

    -10.16%
    DRTS annual cash from operations is down -10.16% year-on-year

    Cash From Investing

    $20.77M
    DRTS annual cash from investing is $20.77 million

    Cash From Investing 1-Year Change

    +11.17%
    DRTS annual cash from investing is up +11.17% year-on-year

    Cash From Financing

    $25.00K
    DRTS annual cash from financing is $25.00 thousand

    Cash From Financing 1-Year Change

    -99.53%
    DRTS annual cash from financing is down -99.53% year-on-year

    CAPEX

    CAPEX

    $2.24M
    DRTS annual capital expenditures is $2.24 million

    CAPEX 1-Year Change

    -65.04%
    DRTS annual capital expenditures is down -65.04% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$22.02M
    DRTS annual free cash flow is -$22.02 million

    Free Cash Flow 1-Year Change

    +9.6%
    DRTS annual free cash flow is up +9.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    DRTS annual gross profit margin value is unknown

    Operating Margin

    -
    DRTS annual operating profit margin value is unknown

    Net Margin

    -
    DRTS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -32.80%
    DRTS annual return on assets is -32.80%

    ROE

    -43.16%
    DRTS annual return on equity is -43.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    DRTS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    DRTS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.42
    DRTS price to book ratio is 5.42

    PB Ratio Sector Percentile

    77.25%
    DRTS price to book ratio is higher than 77.25% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    DRTS price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    DRTS price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $357.97M
    DRTS enterprise value is $357.97 million

    Enterprise Value Sector Percentile

    59.11%
    DRTS enterprise value is higher than 59.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    DRTS EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    DRTS EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    7.40
    DRTS annual current ratio is 7.40

    Quick Ratio

    7.40
    DRTS annual quick ratio is 7.40

    Leverage

    Debt To Equity

    0.20
    DRTS annual debt to equity ratio is 0.20

    Interest Coverage Ratio

    -
    DRTS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    DRTS piotroski f-score value is unknown

    Altman Z-Score

    7.89
    DRTS altman z-score is 7.89

    Analyst ratings

    Recent major analysts updates

    Dec 10, 25 Citigroup
    Buy
    Nov 24, 25 HC Wainwright & Co.
    Buy
    Oct 22, 25 HC Wainwright & Co.
    Buy
    Sep 3, 25 HC Wainwright & Co.
    Buy
    Apr 29, 25 HC Wainwright & Co.
    Buy
    Mar 17, 25 HC Wainwright & Co.
    Buy
    Nov 22, 24 HC Wainwright & Co.
    Buy
    Oct 23, 24 HC Wainwright & Co.
    Buy
    Oct 11, 24 HC Wainwright & Co.
    Buy
    Aug 20, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with DRTS included

    Growing Shares Outstanding
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Alpha Tau Medical Ltd.?
    • Does Alpha Tau Medical Ltd. pay dividends?
    • What sector is Alpha Tau Medical Ltd. in?
    • What industry is Alpha Tau Medical Ltd. in?
    • What country is Alpha Tau Medical Ltd. based in?
    • When did Alpha Tau Medical Ltd. go public?
    • Is Alpha Tau Medical Ltd. in the S&P 500?
    • Is Alpha Tau Medical Ltd. in the NASDAQ 100?
    • Is Alpha Tau Medical Ltd. in the Dow Jones?
    • When was Alpha Tau Medical Ltd.'s last earnings report?
    • When does Alpha Tau Medical Ltd. report earnings?

    What is the ticker symbol for Alpha Tau Medical Ltd.?

    The ticker symbol for Alpha Tau Medical Ltd. is NASDAQ:DRTS

    Does Alpha Tau Medical Ltd. pay dividends?

    No, Alpha Tau Medical Ltd. does not pay dividends

    What sector is Alpha Tau Medical Ltd. in?

    Alpha Tau Medical Ltd. is in the Healthcare sector

    What industry is Alpha Tau Medical Ltd. in?

    Alpha Tau Medical Ltd. is in the Biotechnology industry

    What country is Alpha Tau Medical Ltd. based in?

    Alpha Tau Medical Ltd. is headquartered in Israel

    When did Alpha Tau Medical Ltd. go public?

    Alpha Tau Medical Ltd.'s initial public offering (IPO) was on March 8, 2021

    Is Alpha Tau Medical Ltd. in the S&P 500?

    No, Alpha Tau Medical Ltd. is not included in the S&P 500 index

    Is Alpha Tau Medical Ltd. in the NASDAQ 100?

    No, Alpha Tau Medical Ltd. is not included in the NASDAQ 100 index

    Is Alpha Tau Medical Ltd. in the Dow Jones?

    No, Alpha Tau Medical Ltd. is not included in the Dow Jones index

    When was Alpha Tau Medical Ltd.'s last earnings report?

    Alpha Tau Medical Ltd.'s most recent earnings report was on November 20, 2025

    When does Alpha Tau Medical Ltd. report earnings?

    The next expected earnings date for Alpha Tau Medical Ltd. is March 12, 2026
    On this page